EGFR mutations occurred in 11 tumours and mostly co-occurred with TP53 in 6 of these tumours, whilst ACVR1 mutations were also present in 11 tumours and co-occurred with PIK3CA/PIK3R1 mutations in 6 (Fig. 3A). Here, PIK3CA is linked to neoplasm.